1. Home
  2. CEV vs ICCC Comparison

CEV vs ICCC Comparison

Compare CEV & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eaton Vance California Municipal Income Trust Shares of Beneficial Interest

CEV

Eaton Vance California Municipal Income Trust Shares of Beneficial Interest

HOLD

Current Price

$10.12

Market Cap

73.6M

Sector

Finance

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

HOLD

Current Price

$10.02

Market Cap

75.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CEV
ICCC
Founded
N/A
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.6M
75.8M
IPO Year
1998
1995

Fundamental Metrics

Financial Performance
Metric
CEV
ICCC
Price
$10.12
$10.02
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
19.3K
28.0K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
53.85
EPS
N/A
0.21
Revenue
N/A
$26,493,169.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
51.64
52 Week Low
$9.35
$4.52
52 Week High
$10.78
$10.25

Technical Indicators

Market Signals
Indicator
CEV
ICCC
Relative Strength Index (RSI) 45.02 73.69
Support Level $10.11 $5.85
Resistance Level $10.22 N/A
Average True Range (ATR) 0.11 0.50
MACD -0.03 0.12
Stochastic Oscillator 29.17 97.37

Price Performance

Historical Comparison
CEV
ICCC

About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest

Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.

About ICCC ImmuCell Corporation

ImmuCell Corp is an animal health biologics company focused on the development, manufacture, and commercialization of products intended to improve the survivability, health, and long-term performance of neonatal dairy and beef calves. Its product, First Defense, utilizes hyperimmunized bovine colostrum to provide pathogen-specific antibodies and other bioactive components. First Defense is designed to provide Immediate Immunity through orally delivered antibodies against the principal viral and bacterial causes of neonatal calf diarrhea (scours), including Escherichia coli (E.coli), bovine coronavirus, and bovine rotavirus. It has two operating segments: Scours and Mastitis. It derives the majority of the revenue from the Scours segment that consists of the First Defense product line.

Share on Social Networks: